U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A Amendment No. 1 (MARK ONE) [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 1997 [ ] TRANSITION REPORT UNDER SECTION 13 OR A5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (no fee required) Commission file number 0-23544 EROX CORPORATION ---------------------------------------------- (Name of small business issuer in its charter) California 94-3107202 - ------------------------------------------------------------- ----------------------------------- (State or other jurisdiction of incorporation or organization) (I.R.S. employee Identification No.) 4034 Clipper Court, Fremont, California 94538 - ------------------------------------------------------------- ----------------------------------- (Address of principal executive offices) (Zip code) Issuer's telephone number: (510) 226-6874 Check whether the Issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X ] No [ ] (APPLICABLE ONLY TO CORPORATE REGISTRANTS) State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date. 10,289,488 shares of Common Stock as of July 31, 1997. Total Pages: 26 EROX CORPORATION INDEX Page ---- PART I FINANCIAL INFORMATION Item 1. Financial Statements Condensed Balance Sheets (Unaudited) as of June 30, 1997 and December 31, 1996...........................................................................2 Statements of Operations (Unaudited) for the Three Months and Six Months Ended June 30, 1997 and 1996..........................................................................3 Statements of Cash Flows (Unaudited) for the Six Months Ended June 30, 1997 and 1996....................................................................4 Notes to Condensed Financial Statements (Unaudited).............................................5 Item 2. Management's Discussion and Analysis Management's Discussion and Analysis of Financial Condition and Results of Operations...........6 PART II OTHER INFORMATION Item 4. Submission of Matters to Vote of Security Holders................................................9 Item 6. Exhibits and Reports on Form 8-K.................................................................9 SIGNATURES.......................................................................................................10 PART I FINANCIAL INFORMATION Item 1. Financial Statements EROX CORPORATION Condensed Balance Sheets (unaudited) June 30, December 31, 1997 1996 ----------------- ----------------- (Restated) Assets Current assets: Cash and cash equivalents $ 7,886 $ 2,059,084 Accounts receivable, net of allowances of $541,383 1,379,620 2,813,135 and $501,677 in 1997 and 1996, respectively Inventory 4,806,498 2,906,517 Other current assets 94,253 74,414 ----------------- ----------------- Total curren assets 6,288,257 7,853,150 Property and equipment, net 131,749 71,516 ----------------- ----------------- $ 6,420,006 $ 7,924,666 ================= ================= Liabilities and Shareholders' equity Current liabilities: Accounts payable $ 1,113,759 $ 1,218,741 Loan payable, bank 1,943,706 500,000 Other accrued expenses 1,488,881 876,320 ----------------- ----------------- Total current liabilities 4,546,346 2,595,061 Commitments - - Shareholders' equity: Convertible preferred stock, issuable in series, no par value, 10,000,000 shares authorized, no shares issued and outstanding - - Common stock, no par value, 40,000,000 shares authorized, 10,289,488 and 10,156,905 shares issued and outstanding at June 30, 1997 and December 31, 1996, respectively 17,667,023 17,374,734 Accumulated deficit (15,793,363) (12,045,129) ----------------- ----------------- Total shareholders' equity 1,873,660 5,329,605 ----------------- ----------------- $ 6,420,006 $ 7,924,666 ================= ================= <FN> See accompanying notes </FN> EROX CORPORATION Condensed Statements of Operations (unaudited) Three months ended June 30, Six months ended June 30, ---------------------------------------------------------------- 1997 1996 1997 1996 --------------- --------------- -------------- -------------- (Restated) (Restated) Net sales $ 3,817,542 $ 5,142,144 $ 8,913,831 $ 9,193,002 Cost of goods sold 981,957 1,451,520 1,889,643 2,511,362 ------------ ------------ ------------ ------------ Gross profit 2,835,585 3,690,624 7,024,188 6,681,640 Expenses: Research and development 73,086 78,269 164,856 161,306 Selling, general and administrative 6,677,523 3,515,559 10,584,801 6,372,716 ------------ ------------ ------------ ------------ Total expenses 6,750,609 3,593,828 10,749,657 6,534,022 ------------ ------------ ------------ ------------ Income (loss) from operations (3,915,024) 96,796 (3,725,469) 147,618 Interest income 491 206 12,471 12,828 Interest expense 34,285 1,023 36,828 2,459 Other income 918 3,624 2,392 1,627 ------------ ------------ ------------ ------------ Income (loss) before taxes (3,947,900) 99,603 (3,747,434) 159,614 Provision/(benefit) for income taxes (9,983) -- 800 -- ------------ ------------ ------------ ------------ Net income (loss) $ (3,937,917) $ 99,603 $ (3,748,234) $ 159,614 ============ ============ ============ ============ Net income (loss) per share $ (0.38) $ 0.01 $ (0.37) $ 0.02 ============ ============ ============ ============ Shares used in calculation of net income (loss) per share 10,284,323 10,499,030 10,252,966 10,375,896 ============ ============ ============ ============ EROX CORPORATION Statements of Cash Flows (unaudited) Six months ended June 30, 1997 1996 ----------------- ----------------- (Restated) Cash Flows from Operating Activities Net income (loss) $(3,748,234) $ 159,614 Adjustments to reconcile net income (loss) to net cash used in operating activities: Depreciation and amortization 31,695 65,824 Changes in operating assets and liabilities: Accounts receivable 1,433,515 (934,481) Inventory (1,899,981) (1,132,924) Other current assets (19,839) 120,748 Accounts payable and accrued liabilities 507,579 697,751 ----------- ----------- Net cash used in operating activities (3,695,265) (1,023,468) Cash Flows from Investing Activities Purchase of property and equipment (91,928) (50,953) ----------- ----------- Net cash used in investing activities (91,928) (50,953) Cash Flows from Financing Activities Proceeds from issuance of common stock 292,289 134,966 Proceeds from (payments on) bank borrowings 1,443,706 (500,000) ----------- ----------- Net cash provided by (used in) financing activities 1,735,995 (365,034) Net decrease in cash and cash equivalents (2,051,198) (1,439,455) Cash and cash equivalents at beginning of the period 2,059,084 2,186,828 ----------- ----------- Cash and cash equivalents at end of the period $ 7,886 $ 747,373 =========== =========== EROX Corporation Notes to Condensed Financial Statements (Unaudited) June 30, 1997 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-QSB and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 1997 are not necessarily indicative of the results that may be expected for the calendar year ending December 31, 1997. For further information, refer to the financial statements and footnotes thereto included in the Company's annual report on Form 10-KSB for the year ended December 31, 1996. Restatement of Financial Statements Prior to filling the form 10QSB for the third quarter of 1997, the Company determined that its previously reported operating results and balance sheet data for the three month and six month periods ended June 30, 1997 required adjustment. Revisions to these periods have been made as a result of previously unknown chargebacks for cooperative advertising expenditures applicable to the second quarter's operations of 1997 but not reported or charged to the Company by department stores until the third quarter of 1997. These charges result in the restatement of the Company's net loss as shown in the table below: Three Months Ended Six Months Ended June 30 June 30 1997 1997 1997 1997 (Reported) (Restated) (Reported) (Restated) Net (loss) $ (2,953,638) $ (3,937,917) $ (2,763,955) $ (3,748,234) ================ ================== ================= ================= Net (loss) per share $ (0.29) $ (0.38) $ (0.27) $ (0.37) ================ ================== ================= ================= Shares used in calculation of (loss) per share 10,284,323 10,284,323 10,252,966 10,252,966 The financial statements included herein reflect this restatement. Inventory Inventories are stated at the lower of cost (first in - first out method) or market. The inventory at June 30, 1997 consists of finished goods inventory valued at $2,200,319, work in process of $350,725 and raw materials of $2,255,454. At December 31, 1996, these balances were $1,188,882, $154,347 and $1,563,288, respectively. Net Income (Loss) Per Share Net income per share is computed using the weighted average number of shares of common stock outstanding and common equivalent shares from stock options. The latter are excluded from the computation of net loss per share as their effect is antidilutive. 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued) Accounting Pronouncements In February, 1997, the Financial Accounting Standards Board issued Statement No. 128, Earnings Per Share, which is required to be adopted by the Company on December 31, 1997. At that time, the Company will be required to change the method currently used to compute earnings per share and restate all prior periods. Under the new requirements for calculating primary earnings per share, the dilutive effect of stock options will be excluded. There is expected to be no impact on primary earnings per share for either the three or six month periods ended June 30, 1996 or June 30, 1997. The impact of Statement 128 on the calculation of fully diluted earnings per share for these quarters is not expected to be material. Subsequent Events On July 1, 1997, the Company renegotiated its Business Loan Agreement with Mid Peninsula Bank of Palo Alto, California. The Company may borrow up to $3.0 million at an interest rate equal to the bank's prime rate plus .75% with borrowings secured primarily by the Company's trade receivables and inventory. The agreement, which expires on April 1, 1998, contains certain debt-to-equity and working capital covenants. Subsequent to June 30, 1997, the Company reached an agreement to obtain additional equity capital from affiliates of a current shareholder by issuing 1,433,333 shares of convertible preferred stock. This investment will provide the Company with $2,150,000 in equity capital that will be used to reduce bank borrowings and finance accounts receivable. Item 2. Management's Discussion and Analysis This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for the historical information contained in this discussion and analysis of financial condition and results of operations, the matters discussed herein are forward looking statements. These forward looking statements include but are not limited to the Company's plans for sales growth and expansion into new channels of trade, expectations of gross margin, expenses, new product introduction, and the Company's liquidity and capital needs. These matters involve risks and uncertainties which include but are not limited to the acceptance of new products, the credit risk associated with consolidation in the retail trade, the costs of components and advertising associated with product retail roll-out and new product introductions, supply constraints or difficulties, the impact of competitive pricing or government regulation and the risk of diverted goods in a slow retail environment. These and other factors may cause actual results to differ materially from those anticipated in forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Risk Factors The Company's future results may be affected to a greater or lesser degree by the following factors among others: Competition: The prestige fragrance market is volatile and extremely competitive. Consumer preferences and demands can shift dramatically reflecting changes in fashion and current fads. There are numerous fragrance products which are better known than the products marketed by the Company. There are also many companies which have substantially greater resources than EROX and which have the ability to invest heavily in new product development and introduction. The Company can expect that its competitors will attempt to compete with the Company through the introduction of new products and promotion of existing products. In addition, the product life cycle of fragrances is shortening. Traditional fragrance companies now introduce a new fragrance every one to two years compared to every four to five years as in the past. This increase in competing fragrances makes it difficult for any one fragrance to hold the consumer's attention on a long-term basis. Although the Company believes the inclusion of human pheromones as a component clearly differentiates its products, other fragrances are competing for space with the Company's products at both the store level and in print and media advertising. Marketing: The failure to establish and maintain the necessary sales or distribution channels could have a material adverse effect on the Company's business. Although the Company believes its marketing strategy is the most cost effective way to introduce its products, there can be no assurance that broader-scale retail launches will be successful. The Company cannot guarantee that retail outlets or catalogues will continue to carry the EROX products. If the current strategy is unsuccessful, marketing of the Company's products would require a new strategy and may require a significantly more expensive sales effort for which the Company may not have sufficient funds. Retail environment: Continued consolidation in the retail trade has led to the emergence of four major retail players who control the major share of the market. Federated Department Stores, The May Company, Dayton Hudson/Marshall Fields and Dillard Department Stores now comprise the majority of U.S. better priced department stores. This consolidation could lead to price and promotional pressure and increased credit risk for the Company. The major U.S. retailers are also moving away from the traditional service oriented environment toward one that is based on "value pricing" and self service. This change in emphasis away from trained sales personnel and retailer support of manufacturer's products has created an environment that values "newness" and price above quality and value. In light of these changes in the retail environment, the Company may find it necessary to seek alternate channels of distribution to sell their products. Seasonality: Sales in the fragrance industry are generally seasonal, with generally higher sales in the second half of the calendar year as a result of increased demand for fragrance products in anticipation of and during the Christmas holiday season. The anticipated seasonality of the Company's sales could cause a significant variation in its quarterly operating results. Patent protection: There can be no assurance that any patent or patent application owned or controlled by the Company will continue to provide commercially significant protection of the Company's technology or ensure that the Company may not be determined to infringe valid patents of others. No assurance can be given that others will not independently develop substantially equivalent proprietary information or otherwise gain access to the Company's trade secrets or that the Company can meaningfully protect its technology, proprietary information or trade secrets. Attraction and retention of key employees: The success of the Company's future operations depends in large part on the Company's ability to recruit and retain key employees and consultants with research, product development and marketing experience, as well as other professionals who are in considerable demand. There can be no assurance that the Company will be successful in retaining or recruiting such key personnel. Dependence on third parties for manufacturing: The Company does not have facilities to manufacture its products and relies on Pherin to manufacture its pheromones and third parties to supply components and to blend, fill and package its fragrance products. The Company believes that such manufacturing services are the most effective method of producing its products. Contract fillers are used by the majority of the fragrance industry, and the Company has no current plans to set up its own filling facilities. However, as with any business that is not vertically integrated, if the Company is unable to obtain or retain fragrance suppliers, component manufacturers or third party manufacturing on acceptable terms, it may not be able to obtain commercial quantities of its products, which would adversely affect results. Results of Operations Three Months ended June 30, 1997 as compared to the Three Months ended June 30, 1996 Net sales for the second quarter of 1997 were $3,817,542 compared to $5,142,144 for the second quarter of 1996. Three factors were primarily responsible for the decline: first, retailers began the year 1997 with higher than expected overall fragrance inventories, second, 1997 witnessed the beginning of an industry wide trend in department store retailing to increase inventory turns from 3 to 6 times per year, and lastly, the industry has been experiencing overall negative growth in the department store fragrance category. These factors adversely affected the demand for the Company's products as retailers adjusted fragrance stocks in-line with new inventory level directives and delayed making purchases until chain-wide fragrance department inventories achieved desired levels. During the second quarter of 1996, the Company continued to open new regional department stores. Castner Knott, Elder Beerman, McCrae's, Parisian's, Profitt's, Von Maur, and Younkers were opened during the second quarter of 1996. The Company also doubled its presence in the California market by opening an additional 45 doors of the Macy's West division of Federated Department Stores. Also in the second quarter of 1996, opening orders were shipped to two distributors in the Middle East. The comparison of sales for these periods is as follows: - ------------------------------------------------------------------------------- Class of Trade 1997 1996 - ------------------------------------------------------------------------------- US Department Store/Retail $ 3,495,408 $ 4,674,278 Duty Free and International 318,283 447,121 Direct Marketing 3,851 20,745 ---------------- ----------------- Net Sales $ 3,817,542 $ 5,142,144 Gross margin increased 2 points in the first quarter of 1997 from the prior year's quarter (to 74% in 1997 from 72% in 1996) due to the Company's success at lowering cost of goods of the primary and secondary packaging of its Realm(R) fragrance products. Overall gross margins have increased as the Company has reduced costs on both in-line and promotional products. Future quarters may have a different gross margin depending on the demand for promotional products and the percentage of higher margin department store sales in comparison to sales through third party distributors. Gross margin in the second quarter of 1996, reflected the Company's previous overall higher cost of goods structure. Research and Development expenses for the second quarters of 1997 and 1996 were $73,086 and $78,269, respectively. These costs principally reflect payments and costs under the Company's contract with Pherin Corporation. Selling and marketing expenses increased to $6,031,420 (158% of sales) in the three months ended June 30, 1997 from $3,171,093 (62% of sales) in the period ended June 30, 1996. This dollar increase is the result of advertising and promotional activities to support the launch of inner Realm(TM) and Realm Women and Realm Men in domestic department store retailers. Many of these expenditures had been committed to as far back as the fourth quarter of 1996, and the Company was unable to change or alter these programs in the short term when sales did not materialize to support these levels of expenditure. Additionally, the Company subsequently received unanticipated chargebacks against accounts receivable payments from many of its department store customers that were not authorized within Company established procedures. The Company has increased its controls on cooperative advertising expense authorization and communicated these tightened policies to all employees, customers and suppliers. During the second quarter of 1997, General and Administrative costs increased due to headcount, consulting and legal expenditures. Clerical headcount additions were made in the later half of 1996 to process the administrative aspects of the Company's larger customer base. Up front legal costs were incurred for foreign trademark and patent work to prepare for expansion into additional foreign markets. Interest income was $491 and $206 for the second quarters of 1997 and 1996, respectively. The Company paid $34,285 in interest expense in the second quarter of 1997 on balances on its revolving bank line of credit. This compares to $1,023 interest expense in the second quarter of 1996. The provision for income taxes for the three months ended June 30, 1997 reflects a benefit of $9,983. This benefit effectively reverses the tax provision recorded in the first quarter as a result of decreased estimated pretax income for the year. Six Months ended June 30, 1997 as compared to the Six Months ended June 30, 1996 Net sales for the six months ended June 30, 1997 were $8,913,831. This was a 3% decrease over net sales of $9,193,002 for the first half of 1996, the result of decreased purchases of fragrance products by its customers due to inventory contraction policies imposed by the major department store chains. During the first six months of 1997, the Company launched its second women's fragrance, inner Realm. This fragrance was rolled out by a majority of the Company's retailers including the Federated chains, Dillard Department Stores, Mercantile and several independent local retailers. The Company did not achieve anticipated levels of initial sell-in with the launch of inner Realm, in part because its retail customers have initiated a process of decreasing overall inventories to increase inventory turns from 3 per year to 6 per year. During the first six months of 1997, the Company made its first shipments to a distributor servicing alternative distribution channels. - -------------------------------------- ----------------------------------------- Class of Trade 1997 1996 - -------------------------------------- ----------------------------------------- US Department Store/Retail $ 8,242,518 $ 8,619,982 Duty Free and International 662,471 523,123 Direct Marketing 8,842 49,897 ---------------- ---------------- Net Sales $ 8,913,831 $ 9,193,002 Gross margin for the first half of 1997 was 79% compared to 73% for the same period in 1996. This increase is the result of decreases in the Company's cost of goods structure. The Company has aggressively sought new suppliers and manufacturing processes in order to decrease the cost of its distinctive primary packaging. These changes have resulted in more competitively costed products. The Company has also created gift and promotional sets using cosmetic modifications of its signature bottles. The lower cost of these sets has allowed the Company to achieve targeted gross margins at the same time as providing a perceived value to the consumer. Research and Development expenses for the first half of 1997 and 1996 were $164,856 and $161,306, respectively and are principally comprised of payments under the Company's contract with Pherin Corporation. Selling and marketing expenses increased to $9,290,583 in the six months ended June 30, 1997 from $5,658,489 in the period ended June 30, 1996. In 1997, the Company incurred expenses to launch its second women's fragrance: inner REALM. Due to the differing advertising requirements of the Company's department store customers, future advertising plans will be evaluated and targeted to suit specific regional and consumer preferences. On going expenses in the sales and marketing area are radio advertising and fragrance modeling to support local in-store promotions and to support the REALM brand in general, headcount and commissions. The Company's general and administrative expenses increased due to additional headcount in distribution and accounting to support the Company's larger customer base. Interest income was $12,471 and $12,828 for the first half of 1997 and 1996, respectively. In 1997, the Company paid $36,828 in interest expense related to advances under its bank line of credit. During the first half of 1996, the Company had interest expense of $2,459. LIQUIDITY At June 30, 1997, the Company had working capital of $1,741,911. Net cash used in operating activities was $3,695,265 for the six months ended June 30, 1997. On July 1, 1997, the Company renegotiated its Business Loan Agreement with Mid-Peninsula Bank of Palo Alto, California. The Company may borrow up to $3,000,000 at an interest rate equal to the bank's prime rate plus .75% with borrowings primarily secured by the Company's trade receivables and inventory. The agreement, which has a one year term, contains certain debt to equity and working capital covenants. Under the terms of the renegotiated bank line, the Company may borrow against both eligible accounts receivable and eligible inventory. There were borrowings totaling $1,943,706 at June 30, 1997. Assuming the Company's activities proceed substantially as planned and if there are no new brand introductions, the Company's current cash, line of credit and anticipated revenues from product sales should be adequate to meet its working capital needs over the next twelve months. Working capital requirements will primarily be for the supply of inventory, staffing, product promotion and training and accounts receivable financing. If the Company fails to achieve significant revenues from its 1997 marketing efforts or if ongoing business proves to be more capital intensive than planned or if the Company elects to develop and launch a new brand, additional funding may be required. Furthermore, additional working capital may be required should the Company experience a greater than planned success with its retail distribution and new product development. In such instance, funds would be needed for inventory build, accounts receivable financing and staffing purposes. The Company has been presented with several opportunities to obtain additional working capital from current investors. Subsequent to June 30, 1997, the Company reached an agreement to obtain additional equity capital from affiliates of a current shareholder by issuing 1,433,333 shares of convertible preferred stock. This investment will provide the Company with $2,150,000 in equity capital that will be used to reduce bank borrowings and finance accounts receivable. PART II OTHER INFORMATION Item 4. Submission of Matters to Vote of Security Holders Registrant held its annual meeting of shareholders (the "Annual Meeting") on May 15, 1997. At the Annual Meeting, the shareholders elected five directors, Bernard I. Grosser, MD, William P. Horgan, Helen C. Leong, Robert Marx and Michael V. Stern to serve until the next annual meeting and their successors are elected. The number of votes cast for, against or withheld, as well as the number of abstention and broker non-votes as to each director are set forth below: Broker For Against Abstained Non-Votes --- ------- --------- --------- Bernard I. Grosser, MD 8,639,193 15,700 0 0 William P. Horgan 8,639,193 15,700 0 0 Helen C. Leong 8,639,193 15,700 0 0 Robert Marx 8,636,893 18,000 0 0 Michael V. Stern 8,639,193 15,700 0 0 Item 6. Exhibits and Reports on Form 8-K (a) Exhibit 10.14 Business Loan Agreement dated July 1, 1997 E- 14 Exhibit 11-Statement re: Computation of Per Share Earnings E- 25 Exhibit 27.01-Financial Data Schedule E- 26 (b) The Company did not file any reports on Form 8-K during the three months ended June 30, 1997. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant had duly caused this Report to be signed on behalf by the undersigned thereunto duly authorized. EROX CORPORATION Registrant Date: November 10, 1997 /s/ William P. Horgan -------------------------------------------------- William P. Horgan Chairman of the Board and Chief Executive Officer Date: November 10, 1997 /s/ Maxine C. Harmatta -------------------------------------------------- Maxine C. Harmatta CFO, Vice President Finance and Administration